Dystonia 2, torsion, autosomal recessive
Other Names: DYT2; Torsion dystonia 2; Torsion dystonia 2, autosomal recessive type; Dystonia musculorum deformans type 2
Definition[edit]
Primary dystonia DYT2 type is characterized by segmental dystonia that manifests with involuntary posturing affecting predominantly the feet.
Epidemiology[edit]
The exact prevalence is unknown. The disease is reported in a limited number of Jewish and Gypsy families.
Clinical description[edit]
The onset of the symptoms is early in childhood or adolescence. Progression to generalized dystonia is possible.
Cause[edit]
(DYT2) is caused by homozygous or compound heterozygous mutation in the HPCA gene (142622) on chromosome 1p35.
Inheritance[edit]
The DYT2 locus is unknown. Autosomal recessive transmission is suggested.

Symptoms For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. 80%-99% of people have these symptoms
- Torsion dystonia
30%-79% of people have these symptoms
- Blepharospasm(Eyelid spasm)
- Difficulty walking(Difficulty in walking)
- Dysarthria(Difficulty articulating speech)
- Feeding difficulties(Feeding problems)
- Limb dystonia
- Torticollis(Wry neck)
- Tremor
5%-29% of people have these symptoms
- Generalized dystonia
Treatment[edit]
The medication(s) listed below have been approved by the Food and Drug Administration (FDA) as orphan products for treatment of this condition
- Botulinum toxin type A (Brand name: Botox) Treatment of cervical dystonia in adults to decrease the severity of abnormal head position and neck pain associated with cervical dystonia. Treatment of blepharospasm or strabismus associated with dystonia in adults (patients 12 years of age and above).
NIH genetic and rare disease info[edit]
Dystonia 2, torsion, autosomal recessive is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Dystonia 2, torsion, autosomal recessive
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


